Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0080
0.00 (0.00%)
At close: Jul 25, 2025

Diagonal Bio AB Company Description

Diagonal Bio AB (publ) operates as a biotechnology company in Sweden.

The company offers LAMPlify, a customized system for general laboratory use to identify the presence of specific genetic markers for, for example, fungi, viruses, or bacteria.

It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor’s office, surgery, mobile clinics, hospital bedsides, and workplaces and airports.

The company was incorporated in 2020 and is based in Lund, Sweden.

Diagonal Bio AB (publ)
CountrySweden
Founded2020
IndustryBiotechnology
SectorHealthcare
Employees5
CEOKarin Wehlin

Contact Details

Address:
The Spark
Lund, 223 81
Sweden
Phone46 7 03 05 24 88
Websitediagonalbio.com

Stock Details

Ticker SymbolDIABIO
ExchangeNordic Growth Market
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0015961826
SIC Code2835

Key Executives

NamePosition
Karin Wehlin MBAChief Executive Officer
Kushagr PunyaniTech Advisor, Founding Partner and Director
Andreas NybergFounder and Chief Scientific Officer
Johan KallstrandFounding Partner
Fata MrsicChief Financial Officer